Skip to main content
SpringerLink
Log in

Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Sperm-associated antigen 9 (SPAG9) was reported as a novel biomarker for several cancers and associated with the malignant behavior of cancer cells. However, its expression pattern and biological role in human hepatocellular carcinoma (HCC) have not been reported. In the present study, we analyzed SPAG9 expression in human HCC tissues by immunohistochemistry and found that SPAG9 overexpression is correlated with tumor stage (p < 0.001), tumor multiplicity (p = 0.019), tumor size (p = 0.034), AFP levels (p = 0.006), and tumor relapse (p = 0.0017). Furthermore, SPAG9 overexpression is correlated with poor overall survival (p < 0.001) and relapse-free survival (p = 0.002). Transfection of SPAG9 small interfering RNA (siRNA) was performed in Bel-7402 cell line. Colony formation and MTT showed that SPAG9 siRNA knockdown inhibited HCC cell proliferation. We also found that SPAG9 depletion could increase cell apoptosis. In addition, the level of cyclin D1 and cyclin E protein expression was downregulated after siRNA treatment. In conclusion, SPAG9 is overexpressed in human HCC and serves as a prognostic marker. SPAG9 contributes to cancer cell growth through regulation of cyclin proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48(4):1312–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42 Suppl 3:S206–14.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  4. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235(3):373–82.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology. 2001;34(4 Pt 1):707–13.

    Article  CAS  PubMed  Google Scholar 

  6. Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, et al. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res. 2011;17(1):46–55.

    Article  CAS  PubMed  Google Scholar 

  7. Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(2):275–81.

    Article  CAS  PubMed  Google Scholar 

  8. Zhao ZK, Dong P, Gu J, Chen L, Zhuang M, Lu WJ, et al. Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma. Tumour Biol. 2013;34(1):173–80.

    Article  PubMed  Google Scholar 

  9. Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M, et al. N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease. J Biol Chem. 2011;286(9):7619–28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 2005;44(43):14090–6.

    Article  CAS  PubMed  Google Scholar 

  11. Lee CM, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A. 2002;99(22):14189–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Nguyen Q, Lee CM, Le A, Reddy EP. JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. J Biol Chem. 2005;280(34):30185–91.

    Article  CAS  PubMed  Google Scholar 

  13. Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, et al. Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J Cell Biol. 2006;175(3):383–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(2):630–9.

    Article  CAS  PubMed  Google Scholar 

  15. Garg M, Kanojia D, Suri S, Suri A. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth. Cancer. 2009;115(24):5688–99.

    Article  CAS  PubMed  Google Scholar 

  16. Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer. 2009;115(12):2671–83.

    Article  CAS  PubMed  Google Scholar 

  17. Yi F, Ni W, Liu W, Pan X, Han X, Yang L, et al. SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion. Tumour Biol. 2013;34(5):2849–55.

    Article  CAS  PubMed  Google Scholar 

  18. Wang Y, Dong Q, Miao Y, Fu L, Lin X, Wang E. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer. 2013;81(2):266–72.

    Article  PubMed  Google Scholar 

  19. Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J. 2005;389(Pt 1):73–82.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res. 2008;68(20):8240–8.

    Article  CAS  PubMed  Google Scholar 

  21. Gantulga D, Tuvshintugs B, Endo Y, Takino T, Sato H, Murakami S, et al. The scaffold protein c-Jun NH2-terminal kinase-associated leucine zipper protein regulates cell migration through interaction with the G protein G(alpha 13). J Biochem. 2008;144(6):693–700.

    Article  CAS  PubMed  Google Scholar 

  22. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;25(11):1620–8.

    Article  CAS  PubMed  Google Scholar 

  23. Liu Y, Wang L, Lin XY, Wang J, Yu JH, Miao Y, et al. The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells. Tumour Biol. 2013;34(3):1641–50.

    Article  CAS  PubMed  Google Scholar 

  24. Liu K, Luo Y, Tian H, Yu KZ, He JX, Shen WY. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma. Tumour Biol. 2014;35(2):995–1002.

  25. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 2001;61(14):5389–95.

    CAS  PubMed  Google Scholar 

  26. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 1994;54(12):3107–10.

    CAS  PubMed  Google Scholar 

  27. Zhang C1, Ye L, Guan S, Jin S, Wang W, Sun S, Lee KH, Wei J, Liu B. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer. Tumour Biol. 2013;35(3):2047–2051.

  28. Leontieva OV, Blagosklonny MV. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion. Cell Cycle. 2013;12(18):3063–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19(3):2109–17.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Gutierrez GJ, Tsuji T, Cross JV, Davis RJ, Templeton DJ, Jiang W, et al. JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint. J Biol Chem. 2010;285(19):14217–28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Bei’er Road 92, Heping District Shenyang, 110001, Liaoning, People’s Republic of China

    Chengyao Xie, Lin Fu, Nan Liu & Qingchang Li

Authors
  1. Chengyao Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lin Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingchang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chengyao Xie.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, C., Fu, L., Liu, N. et al. Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Tumor Biol. 35, 7685–7691 (2014). https://doi.org/10.1007/s13277-014-2030-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2030-x

Keywords

Search

Navigation